3-Bromo-7,7-dimethyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine, 98%, 50mg

3-Fluoro-4-isopropoxyaniline, 95.0%, 100mg

ethyl 4-amino-1H-pyrazole-5-carboxylate, 95%, 100mg

2-Butenoic acid, 3-methyl-, (1R)-1-(1,4-dihydro-5,8-dihydroxy-1,4-dioxo-2-naphthalenyl)-4-methyl-3-penten-1-yl ester, 25mg

5-Carboxy-2-chlorophenylboronic acid, 97.0%, 5g

3-(4-Methyl-2,5-dioxo-imidazolidin-4-yl)-propionic acid, 95.0%, 250mg

1-Fluoro-2-((trifluoromethyl)sulfonyl)benzene, 95.0%, 25g

6-OXASPIRO[4.5]DECAN-9-OL, 95.0%, 1g

2-(Dihydro-2H-pyran-4(3H)-ylidene)acetonitrile, 95.0%, 1g

2,7-Dihydroxyquinoline, 97.0%, 5g

1,4-dioxane, min 99,5 %, pour la synthèse, stabilisé, 500 ml, emballage en verre

1-(2-aminoethyl)cyclopentanol, 95.0%, 5g

Ethyl 2-(2-iodophenyl)acetate, 95.0%, 1g